Zacks Research Increases Earnings Estimates for Henry Schein

Key Points

• Zacks Research increased its Q4 2025 earnings per share estimate for Henry Schein, projecting earnings of $1.30, up from a previous estimate of $1.29.
• Henry Schein's last earnings report revealed a miss on consensus estimates, reporting $1.10 EPS against an expected $1.19.
• Institutional investors own approximately 96.62% of Henry Schein's stock, reflecting strong interest from large financial entities.

Henry Schein, Inc. (NASDAQ:HSIC - Free Report) - Stock analysts at Zacks Research increased their Q4 2025 earnings per share estimates for shares of Henry Schein in a report released on Tuesday, October 14th. Zacks Research analyst Team now anticipates that the company will earn $1.30 per share for the quarter, up from their previous forecast of $1.29. The consensus estimate for Henry Schein's current full-year earnings is $4.74 per share. Zacks Research also issued estimates for Henry Schein's Q3 2026 earnings at $1.38 EPS.

Henry Schein (NASDAQ:HSIC - Get Free Report) last issued its earnings results on Tuesday, August 5th. The company reported $1.10 earnings per share for the quarter, missing the consensus estimate of $1.19 by ($0.09). Henry Schein had a return on equity of 14.36% and a net margin of 3.05%.The firm had revenue of $3.24 billion during the quarter, compared to analyst estimates of $3.22 billion. During the same period in the previous year, the company earned $1.23 earnings per share. The business's revenue for the quarter was up 3.3% on a year-over-year basis. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS.

Several other brokerages have also weighed in on HSIC. Baird R W lowered Henry Schein from a "strong-buy" rating to a "hold" rating in a research report on Monday, July 14th. Leerink Partners set a $75.00 price objective on Henry Schein in a report on Monday, July 14th. Robert W. Baird restated a "neutral" rating and set a $72.00 target price (down previously from $82.00) on shares of Henry Schein in a research note on Monday, July 14th. UBS Group decreased their target price on Henry Schein from $75.00 to $70.00 and set a "neutral" rating for the company in a research note on Wednesday, August 6th. Finally, Weiss Ratings reaffirmed a "hold (c)" rating on shares of Henry Schein in a research note on Wednesday, October 8th. Five investment analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company's stock. According to MarketBeat, the company has an average rating of "Hold" and an average price target of $76.67.

Henry Schein Stock Performance

Shares of HSIC stock opened at $63.39 on Wednesday. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.41 and a quick ratio of 0.78. Henry Schein has a fifty-two week low of $60.56 and a fifty-two week high of $82.49. The stock's 50-day moving average is $67.31 and its two-hundred day moving average is $68.72. The firm has a market cap of $7.69 billion, a P/E ratio of 20.45, a PEG ratio of 2.08 and a beta of 0.81.

Hedge Funds Weigh In On Henry Schein

Several institutional investors have recently bought and sold shares of the business. Artisan Partners Limited Partnership raised its position in Henry Schein by 0.9% in the 2nd quarter. Artisan Partners Limited Partnership now owns 6,462,204 shares of the company's stock valued at $472,064,000 after purchasing an additional 55,653 shares during the last quarter. JPMorgan Chase & Co. lifted its stake in shares of Henry Schein by 6.5% during the first quarter. JPMorgan Chase & Co. now owns 6,373,036 shares of the company's stock valued at $436,489,000 after acquiring an additional 390,399 shares during the period. Ameriprise Financial Inc. lifted its stake in shares of Henry Schein by 3,275.2% during the second quarter. Ameriprise Financial Inc. now owns 2,266,858 shares of the company's stock valued at $165,594,000 after acquiring an additional 2,199,695 shares during the period. Dimensional Fund Advisors LP lifted its stake in shares of Henry Schein by 4.8% during the first quarter. Dimensional Fund Advisors LP now owns 2,240,933 shares of the company's stock valued at $153,480,000 after acquiring an additional 103,384 shares during the period. Finally, Burgundy Asset Management Ltd. lifted its stake in shares of Henry Schein by 33.9% during the first quarter. Burgundy Asset Management Ltd. now owns 2,235,429 shares of the company's stock valued at $153,105,000 after acquiring an additional 566,530 shares during the period. Institutional investors own 96.62% of the company's stock.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.